FDA.reportPublic FDA data

talazoparib 0.5 MG Oral Capsule

RxCUI
2591510
RxNorm name
talazoparib 0.5 MG Oral Capsule
Display name
talazoparib 0.5 MG Oral Capsule
Full name
talazoparib 0.5 MG Oral Capsule
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TalzennaTALAZOPARIBU.S. Pharmaceuticals13839d4f-6acf-4ffb-a128-79df593192732026-06-01Warnings, Adverse reactionsExact identifier
rxcui: 2591510
TalzennaTALAZOPARIBPfizer Laboratories Div Pfizer Incc6fd147f-a77e-4a0b-9280-e82ecc41b4be2026-04-10Warnings, Adverse reactionsExact identifier
rxcui: 2591510
TalzennaTALAZOPARIBPfizer Laboratories Div Pfizer Incf2423edd-6d24-495c-aec1-c2f457f08d9a2025-12-18Warnings, Adverse reactionsExact identifier
rxcui: 2591510
TalzennaTALAZOPARIBU.S. Pharmaceuticalsb653221e-971f-4452-92d4-797924f1ff592024-07-09Warnings, Adverse reactionsExact identifier
rxcui: 2591510

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
f2423edd-6d24-495c-aec1-c2f457f08d9atalazoparib 0.5 MG Oral CapsuleSCD19These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 201820251218
f2423edd-6d24-495c-aec1-c2f457f08d9atalazoparib 0.5 MG Oral CapsulePSN19These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 201820251218
f2423edd-6d24-495c-aec1-c2f457f08d9atalazoparib 0.5 MG (as talazoparib tosylate 0.727 MG) Oral CapsuleSY19These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 201820251218
c6fd147f-a77e-4a0b-9280-e82ecc41b4betalazoparib 0.5 MG Oral CapsuleSCD4These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 201820260410
c6fd147f-a77e-4a0b-9280-e82ecc41b4betalazoparib 0.5 MG Oral CapsulePSN4These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 201820260410
c6fd147f-a77e-4a0b-9280-e82ecc41b4betalazoparib 0.5 MG (as talazoparib tosylate 0.727 MG) Oral CapsuleSY4These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 201820260410
b653221e-971f-4452-92d4-797924f1ff59talazoparib 0.5 MG (as talazoparib tosylate 0.727 MG) Oral CapsuleSY1These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 201820240709
b653221e-971f-4452-92d4-797924f1ff59talazoparib 0.5 MG Oral CapsuleSCD1These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 201820240709
b653221e-971f-4452-92d4-797924f1ff59talazoparib 0.5 MG Oral CapsulePSN1These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 201820240709